- Home
- DRIO vs OVID Comparison
DRIO vs OVID Comparison
Compare DRIO & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- OVID
- Stock Information
- Founded
- DRIO 2011
- OVID 2014
- Country
- DRIO United States
- OVID United States
- Employees
- DRIO N/A
- OVID N/A
- Industry
- DRIO Medical/Dental Instruments
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- OVID Health Care
- Exchange
- DRIO Nasdaq
- OVID Nasdaq
- Market Cap
- DRIO 28.3M
- OVID 20.6M
- IPO Year
- DRIO N/A
- OVID 2017
- Fundamental
- Price
- DRIO $0.72
- OVID $0.27
- Analyst Decision
- DRIO Strong Buy
- OVID Strong Buy
- Analyst Count
- DRIO 2
- OVID 6
- Target Price
- DRIO $2.50
- OVID $2.78
- AVG Volume (30 Days)
- DRIO 157.7K
- OVID 441.7K
- Earning Date
- DRIO 05-14-2025
- OVID 05-13-2025
- Dividend Yield
- DRIO N/A
- OVID N/A
- EPS Growth
- DRIO N/A
- OVID N/A
- EPS
- DRIO N/A
- OVID N/A
- Revenue
- DRIO $28,034,000.00
- OVID $548,000.00
- Revenue This Year
- DRIO $16.54
- OVID N/A
- Revenue Next Year
- DRIO $21.93
- OVID $21.49
- P/E Ratio
- DRIO N/A
- OVID N/A
- Revenue Growth
- DRIO 47.20
- OVID 15.61
- 52 Week Low
- DRIO $0.50
- OVID $0.24
- 52 Week High
- DRIO $1.57
- OVID $3.31
- Technical
- Relative Strength Index (RSI)
- DRIO 52.54
- OVID 38.31
- Support Level
- DRIO $0.63
- OVID $0.28
- Resistance Level
- DRIO $0.74
- OVID $0.31
- Average True Range (ATR)
- DRIO 0.05
- OVID 0.02
- MACD
- DRIO 0.00
- OVID 0.00
- Stochastic Oscillator
- DRIO 56.73
- OVID 0.34
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.